Leukemic Variant of Mantle Cell Lymphoma: Clinical Presentation and Management-Reference-Cited by-同舟云学术

Leukemic Variant of Mantle Cell Lymphoma: Clinical Presentation and Management

Published:2021-07-16 Issue:9 Volume:23 Page:
ISSN:1523-3790
Container-title:Current Oncology Reports
language:en
Short-container-title:Curr Oncol Rep

Author:

Isaac Krista M.,Portell Craig A.,Williams Michael E.

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11912-021-01094-y.pdf

Reference45 articles.

1. Swerdlow SH, Campo E, Seto M, Muller-Hermelink H. Mantle cell lymphoma. WHO Classif Tumours Haematop Lymphoid Tissues, revised 4th Ed. 2017. p. 285–90.

2. Williams ME, Westermann CD, Swerdlow SH. Genotypic characterization of centrocytic lymphoma: frequent rearrangement of the chromosome 11 bcl-1 locus. Blood. 1990;76:1387–91. https://doi.org/10.1182/blood.V76.7.1387.1387.

3. Williams ME, Meeker TC, Swerdlow SH. Rearrangement of the chromosome 11 bcl-1 locus in centrocytic lymphoma: analysis with multiple breakpoint probes. Blood. United States. 1991;78:493–8.

4. Banks PM, Chan J, Cleary ML, Delsol G, De Wolf-Peeters C, Gatter K, et al. Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol. United States. 1992;16:637–40.

5. Swerdlow SH, Yang WI, Zukerberg LR, Harris NL, Arnold A, Williams ME. Expression of cyclin D1 protein in centrocytic/mantle cell lymphomas with and without rearrangement of the BCL1/cyclin D1 gene. Hum Pathol. United States. 1995;26:999–1004.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissues: B-cell Neoplasms;Modern Pathology;2024-04

2. Survival Outcomes of Patients with Mantle Cell Lymphoma: A Retrospective, 15-Year, Real-Life Study;Hematology Reports;2024-01-18

3. Recent advances in genomics and therapeutics in mantle cell lymphoma;Cancer Treatment Reviews;2024-01

4. Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine–rituximab;British Journal of Haematology;2023-10-25

5. Mantle cell lymphoma involving the oral and maxillofacial region: a study of 20 cases;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2023-01